`
`—————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`—————
`
`SLAYBACK PHARMA LLC,
`Petitioner,
`
`v.
`
`EYE THERAPIES, LLC,
`Patent Owner.
`
`—————
`
`Case No.: IPR2022-00142
`
`U.S. Patent No.: 8,293,742
`
`—————
`
`
`PETITIONER’S MOTION TO SEAL
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. §§ 42.16 and 42.54, Petitioner, Slayback Pharma
`
`LLC, respectfully requests that the Board seal the confidential versions of
`
`Petitioner’s Exhibit Nos. 1047 and 1051 and Petitioner’s Reply, filed herewith.
`
`The portions of the Exhibits that Petitioner seeks to seal contain information that
`
`Patent Owner has identified as confidential pursuant to the proposed protective
`
`order in this proceeding.
`
`Under 35 U.S.C. § 316(a)(1), the default rule is that all papers filed in an
`
`inter partes review are available to the public, but parties may file a motion to seal
`
`confidential information. See also 37 C.F.R. § 42.14 (2021). “The standard for
`
`granting a motion to seal is ‘for good cause.’” Garmin v. Cuozzo, IPR2012-00001,
`
`Paper No. 34 (P.T.A.B. Mar. 14, 2013). The Office Patent Trial Practice Guide
`
`states that the rules “identify confidential information in a manner consistent with
`
`Federal Rule of Civil Procedure 26(c)(1)(G), which provides for protective orders
`
`for trade secret, or other confidential research, development, or commercial
`
`information.” 77 Fed. Reg. 48756, 48760 (2012).
`
`On August 29, 2022, Patent Owner filed a Motion to Seal and Enter
`
`Stipulated Proposed Protective Order. Paper No. 29. With that motion, Patent
`
`Owner identified and served various documents containing information that it
`
`identified as being non-public excerpts of Bausch & Lomb’s NDA and Bausch &
`
`Lomb’s sensitive business and financial information. Id., pp.3-4. Petitioners did
`
`
`
`1
`
`
`
`
`
`not oppose that motion. In this motion, Petitioner seeks to seal documents that
`
`contain information that Patent Owners have identified as confidential pursuant to
`
`the proposed protective order.
`
`I.
`
`Identification of Confidential Information
`
`Petitioner seeks to seal Exhibit No. 1051 in its entirety and portions of
`
`Petitioner’s Reply and Exhibit No. 1047.
`
`Exhibit No. 1051 is the transcript of the deposition of John Ferris, which
`
`Patent Owner designated confidential under the proposed protective order.
`
`Exhibit No. 1047 is the Expert Declaration of Ivan T. Hofmann, which
`
`addresses information that Patent Owner has identified as confidential, including
`
`information that was filed under seal with the Patent Owner Response. A redacted
`
`version of Exhibit No. 1047 is being publicly filed concurrently with this motion.
`
`Petitioner’s Reply similarly addresses information that Patent Owner has
`
`identified as confidential, including information that was filed under seal with the
`
`Patent Owner Response. A redacted version of Petitioner’s Reply is being publicly
`
`filed concurrently with this motion.
`
`II. Good Cause Exists for Sealing the Confidential Information
`
`Petitioner’s Reply and Exhibit Nos. 1047 and 1051 contain information that
`
`Patent Owner has identified as being confidential and sensitive competitive market
`
`analysis, business strategy, and financial information of Bausch & Lomb relating
`
`
`
`2
`
`
`
`
`
`to Lumify®. According to Patent Owner, good cause exists to seal this confidential
`
`information because it contains details about Bausch & Lomb’s sensitive business
`
`information, which is essential to the running of the business. Paper No. 29, pp.5-
`
`6. Based on Patent Owner’s representations, this information would be valuable to
`
`Bausch & Lomb’s competitors and harmful to the company if made public. Id.
`
`Therefore, Petitioner requests that the Board seal the unredacted versions of
`
`Petitioner’s Reply and Exhibit Nos. 1047 and 1051.
`
`III. Certification of Conference with Opposing Party Pursuant to
`37 C.F.R. § 42.54
`
`The parties have conferred and Patent Owner does not oppose this motion.
`
`IV. Conclusion
`
`For the reasons set forth above, Petitioner respectively requests that the
`
`Board grant this motion to seal.
`
`
`
`Dated: December 16, 2022
`
`Respectfully submitted,
`
`
`
`
`
`
`
`By: /Linnea P. Cipriano/
`
`Linnea P. Cipriano
`(Reg. No. 67,729)
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Phone: (212) 813-8800
`
`3
`
`
`
`
`
`
`
`
`
`Cell: (443) 235-1739
`Fax: (212) 937-2204
`lcipriano@goodwinlaw.com
`
`Counsel for Petitioner Slayback
`Pharma LLC
`
`4
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing
`
`PETITIONER’S MOTION TO SEAL was served on December 16, 2022, by
`
`electronic mail to:
`
`Bryan Diner
`
` bryan.diner@finnegan.com
`
`Justin Hasford
`
`Justin.hasford@finnegan.com
`
`Caitlin O’Connell caitlin.oconnell@finnegan.com
`
`Christina Yang christina.yang@finnegan.com
`
`December 16, 2022
`
`Respectfully submitted,
`
` /Linnea P. Cipriano/
`Linnea P. Cipriano
`(Reg. No. 67,729)
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Phone: (212) 813-8800
`Cell: (443) 235-1739
`Fax: (212) 937-2204
`lcipriano@goodwinlaw.com
`
`Counsel for Petitioner Slayback
`Pharma LLC
`
`5
`
`